Novalucol

Quick links to important sections

Novalucol

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Novalucol

Quick Facts

Property Description
Active Ingredients Calcium Carbonate, Magnesium Hydroxide
Form Chewable tablets, Oral suspension
Pharmacological Class Antacid (Non-systemic gastric acid neutralizer)
Common Use Symptomatic relief of Hyperacidity and Heartburn
Origin Chemically derived (Inorganic salt-based)

Novalucol is an Over-the-counter (OTC) combination preparation primarily classified as a non-systemic antacid. Its purpose is to provide immediate, symptomatic relief from acute digestive discomfort associated with excess stomach acid.

Classification: Pharmacological Type and General Purpose

Novalucol belongs to the antacid pharmacological class, which consists of agents that counteract or neutralize acidity within the gastrointestinal tract. As an antacid, it is clinically recognized for the rapid management of symptoms of hyperacidity, including heartburn (pyrosis) and acid-related indigestion (dyspepsia). It functions exclusively as a gastric acid neutralizer to rapidly treat existing symptoms, offering short-acting relief.

Composition and Form: Active Ingredients

The active composition of this medication is a fixed combination of two inorganic salts: Calcium Carbonate (CaCO3) and Magnesium Hydroxide (Mg(OH)2). These chemically derived compounds are the essential acid-buffering agents.

The medication is typically supplied as a chewable tablet or an oral suspension, a pharmaceutical dosage form intended for oral administration. The combination of Calcium Carbonate and Magnesium Hydroxide is utilized to provide a balance of effects. This pairing ensures a high capacity for acid neutralization and a quick onset of action.

High-Level Mechanism of Symptomatic Action

The fundamental physiological action of Novalucol is the direct chemical reaction of its active ingredients with hydrochloric acid in the stomach. This process of acid neutralization consumes the hydrogen ions (H^+), resulting in the rapid elevation of gastric pH to a less corrosive level. This mechanism provides swift, temporary mitigation of the burning sensation and discomfort associated with acid-related symptoms, such as those experienced after a large meal. It functions strictly as a symptomatic treatment, offering short-acting relief upon the onset of symptoms related to acid distress.

Regulatory References

  1. MedlinePlus: Taking Antacids
  2. NIH: Antacids - StatPearls

What side effects are possible with Novalucol?

Possible side effects and safety information

The official safety profile for Novalucol (Calcium Carbonate and Magnesium Hydroxide) distinguishes between common, localized adverse events and rare, systemic safety concerns, as documented by government regulatory authorities.

Adverse Reactions and Frequency

Side effects are primarily classified into System-Organ Classes, with Gastrointestinal Disorders being the most frequently reported category. These include common reactions such as constipation (associated with calcium) and diarrhea (associated with magnesium), alongside general stomach upset.

More significant systemic events affecting Metabolism and Nutrition Disorders are classified as very rare or frequency not known, reflecting reports of hypercalcemia (high calcium levels) and hypermagnesemia (high magnesium levels).


Serious Adverse Reactions and Restrictions

Clinically serious events documented in regulatory labeling include the Milk-Alkali Syndrome, a condition resulting from high-dose, prolonged use that involves hypercalcemia and may lead to renal impairment. Severe hypersensitivity reactions, such as anaphylaxis, are also noted.

Safety restrictions are tied to these systemic risks. The medicine is formally contraindicated in individuals with pre-existing conditions like established hypercalcemia and severe renal insufficiency, as these groups face an increased risk of magnesium toxicity and other serious adverse outcomes. Furthermore, the label notes that the risks of hypercalcemia and related complications are heightened with prolonged use of high doses.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for overdose of this antacid combination (containing Calcium Carbonate and Magnesium Hydroxide) is defined by the risk of systemic electrolyte toxicity, primarily hypercalcemia and hypermagnesemia, which can result from acute excessive ingestion or chronic high-dose exposure. The content below reflects the officially documented signs and required emergency actions.

Documented Overdose Manifestations and Risks

Domain Official Regulatory Statements
Overdose Manifestations Symptoms related to hypercalcemia (e.g., polyuria, nausea, fatigue) and hypermagnesemia (e.g., CNS depression, somnolence, hypotension) are documented in prescribing information.
Severe Systemic Risk Regulatory warnings state the potential for severe outcomes, including documented cardiac arrhythmias, respiratory depression, and acute renal failure in severe cases.
Population Risk Patients with impaired renal function are explicitly noted to be at a significantly higher risk for developing severe electrolyte disturbances during overdose.

Emergency Actions Mandated by Regulators

In the event of suspected overdose or the onset of severe symptoms, the regulatory instruction is to seek immediate medical attention or contact emergency medical services. Treatment is officially described as symptomatic and supportive. This may involve procedures such as intravenous hydration, and continuous electrolyte monitoring (e.g., calcium and magnesium levels) and ECG monitoring are mandated. Regulatory documents specify that no specific antidote is known for this overdose.

Therapeutic Uses of Novalucol

What Novalucol Treats: Main Uses and Benefits

Novalucol is indicated for the symptomatic management of specific types of discomfort and pain. It provides relief for specific pain types, including localized muscle discomfort, temporary joint aches, and certain nerve-related irritation. It is used in clinical scenarios to support individuals dealing with acute symptom flare-ups, as well as providing long-term support for managing chronic symptom domains.

The core benefit Novalucol offers is the softening of symptom severity, which may assist individuals in maintaining daily activities and promoting overall functional well-being. Healthcare providers may recommend this treatment as part of a comprehensive management strategy.


Quick Fact: Symptomatic Relief

Novalucol is designed to influence factors associated with the body’s discomfort signals, supporting symptomatic control in patients.

Regulatory References

  1. NIH MedlinePlus pain management guidance

Eligibility and Restrictions for Use

Who Can and Cannot Use Novalucol?

This section outlines the official population eligibility and non-eligibility rules for Novalucol (Calcium Carbonate and Magnesium Hydroxide), as mandated by government regulatory agencies.


Official Eligibility Constraints

The eligibility profile is strictly defined by regulatory warnings and contraindications related to the medicine's active mineral components.

Classification Eligibility Rules
Absolute Contraindications Use is prohibited for patients with severe renal insufficiency or failure, hypercalcaemia, hypophosphataemia, and pre-existing alkalosis.
Age Restrictions The medicine is approved for unsupervised use in Adults and Adolescents 12 years and older. Use in children under 12 years is not recommended without prior medical direction.
Conditional Use Use requires caution and medical monitoring in patients with mild to moderate renal impairment or a history of kidney stones.
Physiological Status Use during pregnancy and breastfeeding is restricted to short duration and low doses; professional consultation is mandated.

These constraints ensure that Novalucol is used only in populations where the risks of mineral accumulation, electrolyte imbalance, and underlying disease complications are absent or appropriately managed, aligning with official regulatory statements.

What should I know about interactions with other medicines?

The official regulatory profile of Novalucol (Calcium Carbonate, Magnesium Hydroxide) documents interactions that primarily arise from its function as a non-systemic acid neutralizer and the presence of multivalent cations.

Interaction Classifications and Restrictions

Classification Constraint
Exposure-Modifying Interaction Antacid cations can form insoluble chelate complexes with certain orally co-administered drugs, such as Tetracycline and Fluoroquinolone antibiotics, leading to significantly reduced systemic exposure of the antibiotic.
Pharmacodynamic Risk Co-administration with other magnesium-containing preparations or Vitamin D analogs increases the risk of additive toxicity, specifically hypermagnesemia or hypercalcemia, respectively.
pH-Dependent Absorption The increase in gastric pH can reduce the absorption of medicines that require an acidic environment for dissolution, including Ketoconazole and oral Iron salts.

Official Interaction Requirements

To mitigate reduced efficacy, regulatory guidance requires a mandatory timing separation for susceptible medicines; for example, certain antibiotics must be administered at least two hours before or four to six hours after the antacid. Furthermore, the risk of magnesium accumulation and potential toxicity is an officially noted population-specific interaction caution for individuals with renal impairment, whose ability to clear the magnesium component is compromised.

Mechanism of Action

The physiological action of Novalucol is based on two complementary chemical mechanisms localized entirely within the gastrointestinal tract.

Neutralization of Free Hydrogen Ions (Direct Chemical Action)

This mechanistic domain covers the interaction with hydrogen ions (mathbfH^+) and the resulting elevation of gastric pH. The active ingredients, Calcium Carbonate and Magnesium Hydroxide, function as inorganic bases that execute a direct, instantaneous acid-base reaction with the existing hydrochloric acid ( HCl) in the stomach. This chemical consumption of H^+ ions produces a rapid increase in gastric pH, which is the physiological change that results in a reduction of chemonociceptive signaling potential along the mucosal lining.

Component Synergy and Action Constraints

This domain addresses the complementary kinetics and physiological constraints of the combination. Magnesium Hydroxide provides neutralization due to high-rate neutralization kinetics, while Calcium Carbonate provides buffering capacity determined by lower solubility. The entire mechanism is non-systemic and is inherently limited in duration by the gastric emptying process, which physically removes the neutralizing salts, defining its short-duration mechanism of action.

Dosage and Administration Information

Administration and Dosage Regimens

Novalucol, an antacid combination of calcium carbonate and magnesium hydroxide, is administered exclusively through the oral route. Standard labeling establishes clear principles for its proper use, focusing on administration method, frequency, and defined duration limits.


Procedural Administration Requirements

Official dosage forms include the chewable tablet and the oral suspension. Proper use requires specific procedural steps. Chewable tablets must be thoroughly chewed before swallowing, and they are not to be ingested whole. For the oral suspension, the bottle must be shaken well prior to measuring and administering the dose to ensure an even distribution of the active ingredients.


Dosing and Frequency

The standard adult dose (for individuals 12 years of age and older) is typically 2 to 4 units (tablets or milliliters of liquid) taken per dose. The administration pattern is intended for use as symptoms occur (prn use), although a scheduled pattern of taking the dose after meals and at bedtime is also described in labeling. A strict maximum daily dose is specified on the label and must not be exceeded.


Duration and Use Constraints

The use of the medicine at its maximum labeled dosage is restricted to a short-term duration of no more than 14 consecutive days. This constraint defines the approved high-level usage perimeter. Official labeling generally does not provide specific dose adjustments for older adults or patients with renal or hepatic impairment, deferring to the standard adult regimen.

Recent Clinical Evidence

Evidence for Use in Heartburn and Acid Indigestion

Research has examined Novalucol's use in individuals experiencing conditions characterized by fluctuating or episodic manifestations of heartburn and acid indigestion. These studies were primarily relevant in trials assessing short-term or episodic symptom patterns and focused on patient-reported outcomes describing perceived discomfort. Findings describe patterns observed in the studies where Novalucol was evaluated in settings of acute symptom activity. The data show patterns related to how symptoms evolved after use in the observed populations. Research does not determine whether an individual will respond similarly.


Evidence for Use in Sour Stomach

Novalucol was studied for its application in managing symptoms of a sour stomach, a condition presenting with cycles of stability and flare-ups. This research was observed in settings with varying symptom burdens and involved studies focusing on episodes where symptoms become more noticeable. The research describes the primary findings related to the patterns of change measured in studies of Novalucol in this common gastrointestinal issue. While studies provide insight into short-term changes, the follow-up durations were limited in many of the trials.


What is Still Uncertain About Novalucol

Long-term effects are not fully established; research describing long-term use, such as over many months or years, is limited. Evidence for use in children is also limited, and studies specifically focused on pregnancy-related populations are typically lacking. The certainty remains low for certain measures due to mixed findings and modest sample sizes in several publications. There are significant research limitation frames to consider, including the fact that evidence quality varies across studies.

Frequently Asked Questions (FAQ)

Common questions about Novalucol (FAQ)


Q: How quickly does Novalucol usually start working?

A: Regulatory information describes the mechanism of Novalucol as a direct chemical reaction that rapidly neutralizes acid in the stomach. While official documents do not provide a specific time frame, the instantaneous nature of this acid-base reaction supports a swift onset of action.


Q: Can Novalucol be used by older adults?

A: Official labeling approves the standard adult dose for individuals 12 years of age and older, which includes older adults. However, labeling generally does not provide specific dose adjustments for older adults. Regulatory information advises consulting a professional if underlying health conditions exist, particularly those affecting the kidneys, which can increase the risk of mineral accumulation.


Q: Is Novalucol appropriate for use in children?

A: Official labeling recommends against the unsupervised use of Novalucol in children under 12 years of age. Use in this population is advised only after receiving medical direction. Studies providing evidence for the use of this medicine in younger children are noted as being limited.


Q: Is there any information about Novalucol's use during pregnancy?

A: Official information indicates that use during pregnancy is typically restricted to short durations and low doses. Professional consultation is required for use during pregnancy or breastfeeding, due to the potential for mineral accumulation. Studies specifically focused on these populations are often lacking.


Q: Are there restrictions on how often Novalucol can be used?

A: Yes, official documents describe use primarily for symptomatic relief as needed (prn use). Regulatory labeling also specifies a strict maximum daily dose and restricts the duration of continuous use to a short term, typically no more than 14 consecutive days.


Q: Do I need to space out Novalucol from other non-prescription drugs?

A: Official warnings state that antacids can interfere with the absorption of other oral medicines, including non-prescription drugs. Regulatory guidance advises a mandatory timing separation of at least two to four hours between Novalucol and susceptible medicines to mitigate reduced efficacy.


Q: What happens if I forget to use Novalucol for a while?

A: Novalucol is intended for use to treat existing symptoms, and its administration pattern is not based on a strict schedule. If a user misses a dose, official regulatory documents do not outline a specific consequence other than the potential return of symptoms.


Q: Are there specific instructions for how to stop using Novalucol?

A: Since Novalucol is approved for short-term symptomatic relief, official instructions do not typically include a tapering schedule or other specific procedure for discontinuation. Use should be stopped once symptoms are managed, but not exceed the defined duration limit.


Q: How long does the effect of Novalucol typically last?

A: Official information indicates that Novalucol is a short-acting treatment. Its effect is limited in duration by the natural process of gastric emptying, which physically removes the neutralizing ingredients from the stomach.


Q: Is Novalucol the same as other medicines for the same condition?

A: Novalucol is classified as a combination preparation containing two active ingredients: Calcium Carbonate and Magnesium Hydroxide. Other medicines for hyperacidity may be single-ingredient antacids, or belong to different pharmacological classes with distinct mechanisms of action.


Q: What kind of relief should I expect from Novalucol?

A: Novalucol is classified as a non-systemic antacid whose function is to neutralize existing stomach acid. This mechanism is intended to provide immediate, symptomatic relief from acute digestive discomforts such as the burning sensation associated with heartburn and acid indigestion.


Q: Do I need a prescription to get Novalucol?

A: No, Novalucol is officially classified as an Over-the-counter (OTC) combination preparation, meaning it is available without a prescription.


Q: Can Novalucol affect my sleep?

A: Official safety profiles for the active ingredients in Novalucol primarily list side effects related to the digestive system. Regulatory documents do not commonly list sleep-related issues, drowsiness, or sedation as frequent or common adverse reactions.


Q: Does Novalucol have any potential interactions with common pain relievers?

A: Yes, official information indicates that the antacid components can decrease the absorption and effectiveness of certain pain relievers, such as aspirin. Regulatory guidance requires separation in administration timing to avoid such an interaction.


Q: Is it safe to take Novalucol with vitamins or supplements?

A: Official warnings note a risk of interaction with Vitamin D analogs and other products containing minerals. Antacids can reduce the absorption of certain minerals and vitamins, such as iron and zinc. A professional consultation may be needed regarding the timing of all supplements.


Q: Are there specific foods or drinks that should be avoided when using Novalucol?

A: Official documents caution against co-administration with excessive amounts of other calcium and magnesium containing preparations. Prolonged, high-dose use of Novalucol, especially with high dietary intake of dairy products, may increase the risk of a serious condition known as Milk-Alkali Syndrome.


Q: Is the active ingredient in Novalucol available in other forms?

A: Yes, the active ingredients, Calcium Carbonate and Magnesium Hydroxide, are widely available in various other dosage forms. These ingredients are commonly found in single-ingredient medicines and as components in other over-the-counter combination products.


Q: Can Novalucol cause changes in mood or energy levels?

A: The official safety profile for Novalucol primarily documents gastrointestinal and metabolic adverse events. Changes in mood or energy levels are not listed as common or frequent adverse reactions in official regulatory documentation.


Q: What is the difference between the brand name Novalucol and its generic equivalent?

A: Regulatory policy defines generic equivalents as containing the identical active ingredients (Calcium Carbonate/Magnesium Hydroxide) and being required to be bioequivalent to the brand name product. This means the generic version is expected to work in the body the same way.


Q: What are the signs that Novalucol might not be working for someone?

A: Official labeling warns that if a user's symptoms persist, return, or worsen after a short course of use (e.g., within 14 days), this may indicate a lack of effectiveness or a serious underlying condition. Official labeling states that these signals may warrant further professional evaluation.


Q: What official bodies have reviewed and approved Novalucol?

A: As a medicine approved for sale, the composition of Novalucol has been reviewed and approved for safety, efficacy, and quality by the respective national government regulatory bodies. These bodies include organizations such as the FDA, EMA, MHRA, and TGA.


Q: Is it normal to feel a mild stomach discomfort when first taking Novalucol?

A: Official safety documents include general stomach upset and other minor gastrointestinal issues, such as constipation or diarrhea, as common adverse reactions. These reactions are typically localized to the digestive system.


Q: Can I drive or operate machinery after using Novalucol?

A: Official safety information for Novalucol does not commonly list side effects like dizziness or drowsiness that would impair mental alertness. Therefore, regulatory documents typically do not impose specific warnings against driving or operating machinery.


Q: Is Novalucol a habit-forming medicine?

A: Novalucol is an antacid, and regulatory agencies do not classify it as a controlled substance. Its mechanism of action is non-systemic, localized to the digestive tract, and does not involve the central nervous system or pathways associated with dependence.


Q: Can Novalucol interfere with lab test results?

A: Yes, official warnings indicate that the active ingredients in Novalucol can interfere with certain laboratory tests. This primarily includes tests that measure levels of serum calcium, phosphate, and magnesium.


Q: What populations were excluded from the main clinical trials for Novalucol?

A: While specific exclusion criteria vary among studies, trials for antacids commonly exclude patients with severe underlying gastrointestinal diseases, such as diagnosed GERD or ulcers, and those with pre-existing metabolic or kidney conditions.


Q: Does taking Novalucol affect the absorption of nutrients?

A: Yes, due to its acid-neutralizing and chelation effects, Novalucol can interfere with the absorption of certain nutrients. This effect is most notable for minerals, such as iron and zinc, and certain vitamins.


Q: Does Novalucol have a sedative effect?

A: Official safety information does not list sedation as a common or frequent adverse reaction. The medicine's action is generally non-systemic and localized to the gastrointestinal tract.


Q: Is Novalucol considered an acute or chronic treatment?

A: Novalucol is classified as an acute symptomatic treatment. It is approved for short-term use and is restricted to defined duration limits to manage temporary episodes of acid-related discomfort.


Q: Can Novalucol be used if I have liver problems?

A: While the primary elimination of the active minerals is through the kidneys, some regulatory documents state that patients with hepatic (liver) impairment may need to seek professional consultation before using antacid combinations.

How should Novalucol be stored and disposed of?

Storage and Disposal Requirements

Novalucol (Calcium Carbonate/Magnesium Hydroxide) must be stored strictly according to its official labeling to maintain product stability and safety. The medication should be kept tightly closed in its original container and stored at room temperature, typically between 15°C and 30°C (59°F and 86°F), away from excess heat and moisture. The liquid suspension form must be protected from freezing.

Child Safety

It is a mandatory safety requirement to keep Novalucol out of the sight and reach of children at all times.

Discarding Expired Product

Unused or expired medication should not be poured down a drain or flushed unless explicitly authorized by regulatory bodies. Patients should utilize drug take-back programs or follow the recommended household disposal method: mixing the product with an undesirable substance (like coffee grounds or dirt) and sealing it in a container before placing it in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Novalucol found in:

A-Z Index: